β-Naphthoflavone treatment attenuates neonatal hyperoxic lung injury in wild type and Cyp1a2-knockout mice

Toxicol Appl Pharmacol. 2018 Jan 15;339:133-142. doi: 10.1016/j.taap.2017.11.017. Epub 2017 Nov 26.

Abstract

Exposure to supraphysiological concentrations of oxygen (hyperoxia) leads to bronchopulmonary dysplasia (BPD), one of the most common pulmonary morbidities in preterm neonates, which is more prevalent in males than females. Beta-naphthoflavone (BNF) is protective against hyperoxic lung injury in adult and neonatal wild type (WT) mice and in and mice lacking Cyp1a1gene. In this investigation, we tested the hypothesis that BNF treatment will attenuate neonatal hyperoxic lung injury in WT and Cyp1a2-/- mice, and elucidated the effect of sex-specific differences. Newborn WT or Cyp1a2-/- mice were treated with BNF (10mg/kg) or the vehicle corn oil (CO) i.p., from postnatal day (PND) 2 to 8 once every other day, while being maintained in room air or hyperoxia (85% O2) for 14days. Hyperoxia exposure lead to alveolar simplification and arrest in angiogenesis in WT as well as Cyp1a2-/- mice No significant differences were seen between WT and Cyp1a2-/- mice. Cyp1a2-/- female mice had better preservation of pulmonary angiogenesis at PND15 compared to similarly exposed males. BNF treatment attenuated lung injury and inflammation in both genotypes, and this was accompanied by a significant induction of hepatic and pulmonary CYP1A1 in WT but not in Cyp1a2-/- mice. BNF treatment increased NADPH quinone oxidoreductase (NQO1) mRNA levels in Cyp1a2-/- mouse livers compared to WT mice. These results suggest that BNF is protective in neonatal mice exposed to hyperoxia independent of CYP1A2 and this may entail the protective effect of phase II enzymes like NQO1.

Keywords: Beta-naphthoflavone; Bronchoplumonary dysplasia; CYP1A2; Hyperoxia; Neonate.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Lung Injury / drug therapy*
  • Acute Lung Injury / genetics
  • Acute Lung Injury / metabolism*
  • Animals
  • Animals, Newborn
  • Cytochrome P-450 CYP1A2 / deficiency*
  • Cytochrome P-450 CYP1A2 / genetics
  • Enzyme Inhibitors / therapeutic use
  • Female
  • Hyperoxia / drug therapy*
  • Hyperoxia / genetics
  • Hyperoxia / metabolism*
  • Male
  • Mice
  • Mice, 129 Strain
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Treatment Outcome
  • beta-Naphthoflavone / therapeutic use*

Substances

  • Enzyme Inhibitors
  • beta-Naphthoflavone
  • Cytochrome P-450 CYP1A2
  • cytochrome P-450 1A2, mouse